Journal
AGING-US
Volume 13, Issue 3, Pages 3239-3253Publisher
IMPACT JOURNALS LLC
Keywords
regulated cell death; naked mole rat; apoptosis; necrosis; DNA damage
Categories
Funding
- Russian Science Foundation [19-74-10056]
- Russian State [0245-2021-0009]
- Russian Science Foundation [19-74-10056] Funding Source: Russian Science Foundation
Ask authors/readers for more resources
The naked mole rat, a long-lived rodent species, displays remarkable resistance to cancer and aging-related diseases. Research shows that naked mole rat cells are more resistant to DNA damaging agents compared to mouse cells, and they may exhibit limited apoptotic response and regulated necrosis. Overall, this study provides new insights into cell death mechanisms in naked mole rats and sheds light on potential therapeutic approaches.
The naked mole rat (NMR), Heterocephalus glaber, is the longest-living rodent species, and is extraordinarily resistant to cancer and aging-related diseases. The molecular basis for these unique phenotypic traits of the NMR is under extensive research. However, the role of regulated cell death (RCD) in the longevity and the protection from cancer in the NMR is still largely unknown. RCD is a mechanism restricting the proliferation of damaged or premalignant cells, which counteracts aging and oncotransformation. In this study, DNA damage-induced cell death in NMR fibroblasts was investigated in comparison to RCD in fibroblasts from Mus musculus. The effects of methyl methanesulfonate, 5-fluorouracil, and etoposide in both cell types were examined using contemporary cell death analyses. Skin fibroblasts from Heterocephalus glaber were found to be more resistant to the action of DNA damaging agents compared to fibroblasts from Mus musculus. Strikingly, our results revealed that NMR cells also exhibit a limited apoptotic response and seem to undergo regulated necrosis. Taken together, this study provides new insights into the mechanisms of cell death in NMR expanding our understanding of longevity, and it paves the way towards the development of innovative therapeutic approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available